Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GROEN, Harry J. M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 58

  • Page / 3
Export

Selection :

  • and

Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancerKRAMER, Henk; GROEN, Harry J. M.Annals of surgery. 2003, Vol 238, Num 2, pp 180-188, issn 0003-4932, 9 p.Article

Diagnosis of mediastinal and left adrenal abnormalities with endoscopic ultrasonographyKRAMER, Henk; GROEN, Harry J. M.Respiratory medicine. 2005, Vol 99, Num 7, pp 926-928, issn 0954-6111, 3 p.Article

Analysis of dry mesothelioma with ultrasound guided biopsiesSTIGT, Jos A; BOERS, James E; GROEN, Harry J. M et al.Lung cancer. 2012, Vol 78, Num 3, pp 229-233, issn 0169-5002, 5 p.Article

Third-line chemotherapy for small cell lung cancerDE JONG, Wouter K; TEN HACKEN, Nick H. T; GROEN, Harry J. M et al.Lung cancer. 2006, Vol 52, Num 3, pp 339-342, issn 0169-5002, 4 p.Article

The prognostic value of positron emission tomography in non-small cell lung cancer : Analysis of 266 casesKRAMER, Henk; POST, Wendy J; PRUIM, Jan et al.Lung cancer. 2006, Vol 52, Num 2, pp 213-217, issn 0169-5002, 5 p.Article

Cardiotoxicity in advanced non-small cell lung cancer Patients treated with platinum and non-platinum based combinations as first-line treatmentWACHTERS, Floris M; VAN DER GRAAF, Winette T. A; GROEN, Harry J. M et al.Anticancer research. 2004, Vol 24, Num 3B, pp 2079-2083, issn 0250-7005, 5 p.Article

Promoter Methylation Primarily Occurs in Tumor Cells of Patients with Non-small Cell Lung CancerDE JONG, Wouter K; VERPOOTEN, Gonda F; KRAMER, Henk et al.Anticancer research. 2009, Vol 29, Num 1, pp 363-369, issn 0250-7005, 7 p.Article

Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trialWESTEINDE, Susan C. Van't; HOREWEG, Nanda; DE LEYN, Paul et al.European journal of cardio-thoracic surgery. 2012, Vol 42, Num 3, pp 420-429, issn 1010-7940, 10 p.Article

CT-quantified emphysema in male heavy smokers: association with lung function declineMOHAMED HOESEIN, Firdaus A. A; DE HOOP, Bartjan; GROEN, Harry J. M et al.Thorax. 2011, Vol 66, Num 9, pp 782-787, issn 0040-6376, 6 p.Article

Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancerDE JONG, Wouter K; GROEN, Harry J. M; KOOLEN, Mia G. J et al.European journal of cancer (1990). 2007, Vol 43, Num 16, pp 2345-2350, issn 0959-8049, 6 p.Article

Selective targeting of homologous DNA recombination repair by gemcitabineWACHTERS, Floris M; VAN PUTTEN, John W. G; MARING, Jan G et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 553-562, issn 0360-3016, 10 p.Article

JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatinFOKKEMA, Eelco; GROEN, Harry J. M; HELDER, Marco N et al.Biochemical pharmacology. 2002, Vol 63, Num 11, pp 1989-1996, issn 0006-2952Article

Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patientsKERBUSCH, Thomas; VAN PUTTEN, John W. G; GROEN, Harry J. M et al.Cancer chemotherapy and pharmacology. 2001, Vol 48, Num 1, pp 53-61, issn 0344-5704Article

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non―Small Cell Lung Cancer with a KRAS MutationDINGEMANS, Anne-Marie C; MELLEMA, Wouter W; GROEN, Harry J. M et al.Clinical cancer research (Print). 2013, Vol 19, Num 3, pp 743-751, issn 1078-0432, 9 p.Article

A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non-Small Cell Lung CancerLIND, Joline S. W; DINGEMANS, Anne-Marie C; VAN SUYLEN, Robert Jan et al.Clinical cancer research (Print). 2010, Vol 16, Num 11, pp 3078-3087, issn 1078-0432, 10 p.Article

Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspirationKRAMER, Henk; SANDERS, Joyce; POST, Wendy J et al.Cancer. 2006, Vol 108, Num 4, pp 206-211, issn 0008-543X, 6 p.Article

Phase II study of docetaxel and carboplatin as second-line treatment in NSCLCWACHTERS, Floris M; VAN PUTTEN, John W. G; BOEZEN, H. Marike et al.Lung cancer. 2004, Vol 45, Num 2, pp 255-262, issn 0169-5002, 8 p.Article

End-joining deficiency and radiosensitization induced by gemcitabineVAN PUTTEN, John W. G; GROEN, Harry J. M; SMID, Kees et al.Cancer research (Baltimore). 2001, Vol 61, Num 4, pp 1585-1591, issn 0008-5472Article

Treatment of brain metastases of small-cell lung cancer : Comparing teniposide and teniposide with whole-brain radiotherapy: A phase III study of the european organization for the research and treatment of cancer lung cancer cooperative groupPOSTMUS, Pieter E; HAAXMA-REICHE, Hanny; SAHMOUD, Tarek et al.Journal of clinical oncology. 2000, Vol 18, Num 19, pp 3400-3408, issn 0732-183XArticle

Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMHDIJKSTRA, Akkelies E; DE JONG, Kim; MARIKE BOEZEN, H et al.Occupational and environmental medicine (London). 2014, Vol 71, Num 5, pp 346-352, issn 1351-0711, 7 p.Article

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non―Small-Cell Lung Cancer: AVAPERL (MO22089)BARLESI, Fabrice; SCHERPEREEL, Arnaud; WONG, Elaine K et al.Journal of clinical oncology. 2013, Vol 31, Num 24, pp 3004-3011, issn 0732-183X, 8 p.Article

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trialHOREWEG, Nanda; VAN DER AALST, Carlijn M; LAMMERS, Jan-Willem J et al.The European respiratory journal. 2013, Vol 42, Num 6, pp 1659-1667, issn 0903-1936, 9 p.Article

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphismGERARD MARING, Jan; WACHTERS, Floris M; SLIJFER, Monique et al.European journal of clinical pharmacology. 2010, Vol 66, Num 6, pp 611-617, issn 0031-6970, 7 p.Article

Management of Lung Nodules Detected by Volume CT ScanningVAN KLAVEREN, Rob J; OUDKERK, Matthijs; THUNNISSEN, Erik et al.The New England journal of medicine. 2009, Vol 361, Num 23, pp 2221-2229, issn 0028-4793, 9 p.Article

Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancersFOKKEMA, Eelco; TIMENS, Wim; DE VRIES, Elisabeth G. E et al.Lung cancer. 2006, Vol 52, Num 2, pp 241-247, issn 0169-5002, 7 p.Article

  • Page / 3